Updated:
Jiangsu Longrich Bio-Science
Jiangsu Longrich Bio-Science is a corporate investor based in Changshu; the Altss profile covers its classification, headquarters, registration, AUM band, and...
Jiangsu Longrich Bio-Science
Jiangsu Longrich Bio-Science is a corporate investor based in Changshu, China, with a regional focus on Asia.
General information
Firm type
Corporate Investor
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Changshu
Corporate office
Changshu, Jiangsu, China
Additional offices
New York, USA · Kobe, Japan · La Rochelle, France · Lagos, Nigeria · Chengdu, China
Principals
Xu Zhiwei
Founder and Chairman
Sector focus
Frequently asked questions
Who controls Jiangsu Longrich Bio-Science?
Founder Xu Zhiwei chairs the company and remains the principal decision-maker. He is also the founder of the broader Longrich group and serves as a representative in the Jiangsu Provincial People's Congress.
What asset classes does the firm invest in?
The firm concentrates on real assets — industrial parks, mixed-use developments, and manufacturing facilities — rather than financial portfolio allocation. Confirmed holdings include the Longrich Bio-Industrial Park in Changshu, Longwin Plaza, and a factory in the Lekki Free Trade Zone in Nigeria.
How is the firm related to the consumer products business?
Jiangsu Longrich Bio-Science acts as the corporate investment entity within the broader Longrich/Longliqi group. The consumer products business — direct selling of health, beauty, and household goods — is the operational engine, while the corporate entity holds and manages the group's real assets and physical infrastructure.
Where are the firm's physical assets located?
The firm maintains operational facilities in Changshu, Chengdu, and Lagos, Nigeria, with R&D centers in New York, Kobe (Japan), and La Rochelle (France). Its real estate portfolio includes several mixed-use and industrial properties in Jiangsu province, China.
Does Jiangsu Longrich Bio-Science operate as a family office?
No. The firm is structured as a corporate investor embedded within an operating conglomerate, not a family office. Investment decisions appear to be made by Xu Zhiwei in his capacity as chairman, not through a dedicated investment committee.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: